Point72 Asset Management
SANA icon

Point72 Asset Management’s Sana Biotechnology SANA Stock Holding History

Point72 Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-300,000
Closed -$489K – 2479
2024
Q4 		$489K Buy
300,000
+100,000
+50% +$298K ﹤0.01% 1668
2024
Q3 		$832K Buy
200,000
+90,000
+82% +$473K ﹤0.01% 1479
2024
Q2 		$601K Buy
+110,000
New +$877K ﹤0.01% 1395

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Point72 Asset Management's SANA Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Sana Biotechnology (SANA) in Q2 2026: 595,091 shares worth $2.08M. The stake represents ﹤0.01% of the portfolio and ranks #2365 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in SANA as recently as Q4 2024.

Point72 Asset Management first reported a position in SANA in Q4 2024 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Point72 Asset Management held 595,091 shares of Sana Biotechnology worth $2.08M as of Q2 2026.
  • Sana Biotechnology was a new Point72 Asset Management position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #2365 holding.
  • Point72 Asset Management first reported a position in Sana Biotechnology in Q4 2024 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.